Detection of low-frequency antigen-specific IL-10-producing CD4 + T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine
Single-cell resolution cytokine ELISPOT assays are increasingly used to gain insights into clonal sizes of type 1 and type 2 effector T cell populations in vivo. However, ELISPOT assays permitting monitoring of regulatory IL-10-producing T cells have so far not been established. Unlike IFN-γ, IL-2,...
Gespeichert in:
Veröffentlicht in: | Journal of immunological methods 2003-08, Vol.279 (1), p.111-121 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Single-cell resolution cytokine ELISPOT assays are increasingly used to gain insights into clonal sizes of type 1 and type 2 effector T cell populations in vivo. However, ELISPOT assays permitting monitoring of regulatory IL-10-producing T cells have so far not been established. Unlike IFN-γ, IL-2, IL-4, and IL-5 assays performed on PBMC in which the recall antigen-induced cytokine spots are T cell-derived, we show here that in such assays IL-10 is primarily monocyte-derived. T cell-derived IL-10 spots were 80×10
3 μm
2 in size, seven times larger than spots produced by monocytes, and B cells produced even smaller spots. Based on spot size gating and the use of B cells as APC, we have established test conditions that permit measurement of cognate IL-10 production by low-frequency antigen-specific T cells. IL-10-producing PPD-specific CD4
+ T cells were detected in frequencies comparable to IFN-γ-secreting CD4
+ T cells in tuberculosis patients, but not in uninfected healthy control individuals. In contrast, IL-10-secreting CD4
+ T cells specific for a panel of recall antigens could not be detected in frequencies >1/100,000 in healthy individuals whose CD4
+ cells responded to these antigens with type 1 or type 2 cytokine production in the 1:100,000–1:1000 frequency range. Therefore, the induction of IL-10-producing T cells seems to be under tighter control than that of Th1/Th2 cells, apparently confined to states of chronic immune stimulation. Access to low-frequency immune monitoring of IL-10-producing T cells will provide new insights into the role of regulatory T cells in health and disease. |
---|---|
ISSN: | 0022-1759 1872-7905 |
DOI: | 10.1016/S0022-1759(03)00240-0 |